PAIM
AVNS

Punch & Associates Investment Management’s Avanos Medical AVNS Stock Holding History

Punch & Associates Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.12M Buy
437,085
+167,085
+62% +$2.25M 0.35% 96
2025
Q4 		$3.03M Buy
+270,000
New +$3.09M 0.18% 120

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Punch & Associates Investment Management's AVNS Position: Q1 2026 in Review

Punch & Associates Investment Management increased its Avanos Medical (AVNS) stake by 62% in Q1 2026, buying an estimated $2.25M and bringing the position to 437,085 shares worth $6.12M. The position accounts for 0.35% of the portfolio, ranked #96.

Punch & Associates Investment Management first reported a position in AVNS in Q4 2025 and has held it in 2 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Punch & Associates Investment Management held 437,085 shares of Avanos Medical worth $6.12M as of Q1 2026.
  • Punch & Associates Investment Management bought 167,085 Avanos Medical shares in Q1 2026, an estimated $2.25M.
  • Avanos Medical made up 0.35% of Punch & Associates Investment Management's portfolio in Q1 2026, its #96 holding.
  • Punch & Associates Investment Management first reported a position in Avanos Medical in Q4 2025 and has held it in 2 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Punch & Associates Investment Management's 13F filing for Q1 2026, filed 15 May 2026.